Italia!!! It’s coming to Rome 🇮🇹 #ForzaAzzurri #EURO2020 #gianluigi

Naheed Nenshi was asked for his reaction tonight to the new round of provincial restrictions. #yyccc

Historic night for #yycvote and #yegvote! The glimpse of light we needed in AB after some dark, dark months.

AND they help keep tattoos sharp AND vacuum-clean debris/old cells AND contribute to our immunity. As if we needed more reasons to love these guys! My OG favourite cell.

Spotify wrap-up but make it nerdy. IYKYK.

Did the EXACT same thing with the program director of the program I desperately wanted to subspecialty match into. Months later I’m thrilled to be in the program and have such an amazing leader/culture. But the memory still gives me palpitations!! 🤦🏼‍♀️

Currently at the point in this pandemic where my bank account has enough data points to create “insights” on my pizza consumption 💁🏼‍♀️ Domino's Pizza #pieceofthepierewards

Absolutely NAILED this one 🤣

My first go at wordle. Had to see what all the fuss (and angry tweets today) were all about. 🤷🏼‍♀️ Wordle 265 5/6 🟨⬜️🟨⬜️🟩 ⬜️🟩🟩🟩🟩 ⬜️🟩🟩🟩🟩 🟨⬜️🟨🟨⬜️ 🟩🟩🟩🟩🟩

Room 10/10 and presentation 10/10! Thank you for sharing your knowledge and passion with us at AHCDC. Excited to work on improving care for women with bleeding disorders as a hematology community!🩸

Our new paper in CMAJ! A network meta-analysis investigating antivirals in non-severe COVID-19 infection!💊 cmaj.ca/content/194/28… Paxlovid >molnupiravir>remdesivir. Dena Zeraatkar Ellen Cusano, MD Faran Khalid McMaster IM Residency Program HEI McMaster University Department of Medicine McMaster University - Waterloo Regional Campus #research #COVID19

The preprint to end all….trial publications?! 📄Pleased to see this published. BMJMedicine Tyler Pitre, MD PhD🇨🇦 Ellen Cusano, MD Gabriel Rada Elena Kum Jessica Bartoszko Chirag Patel

Systematic reviewers, guideline developers & clinicians face a trade-off when considering relying on pre-print evidence. How do pre-prints fare relative to their later publications? Brilliant work by Dena Zeraatkar, published in BMJMedicine, addresses this. bit.ly/3yeNuDI

The best way to kick off #ASH22! Met amazing colleagues and learned from the experts - highly recommend to any trainees interested in classical hematology!

Fortuitous timing - I presented the phase 3 XTEND-1 trial (nejm.org/doi/full/10.10…) for journal club today. Very exciting for patients with hemophilia - a once weekly FVIII prophylaxis option! Will patiently await Health Canada approval …

Choosing a career where every day is #RareDiseaseDay 🩸 >>> Excited to take care of, and do research for, patients with rare bleeding and clotting disorders for the foreseeable future!

It was an absolutely incredible weekend at #ASH24! Congratulations to all of the UCSD faculty and fellow presenters, including Dr. Von Drygalski, Tro Sekayan, Parthiv Sheth, MD, and Ellen Cusano, MD. We are so proud of your work! See the thread below for more details! 🩸

Congratulations to Hemostasis and Thrombosis fellow, Ellen Cusano, MD, on her oral presentation: Clinical and Economic Outcome Analysis of First-Line Immunosuppression in Acquired Hemophilia A!